kinase activation (9-11). Recently, it was shown that GRB2 couples the Ras guanine nucleotide releasing factor (GRF), Sos, to IRS-1 (12-14) . The finding that GRB2 overexpression enhances insulin-induced activation of Ras and Map kinases suggests that binding of GRB2 to IRS-1 may directly link the insulin receptor to Ras signaling pathways (13).
dodding protein that coordinates the regulation of various different signg pathways activated by the insulin receptor.
Many growth factors mediate their effects, such as cell growth and differentiation, by interacting with transmembrane receptors that contain tyrosine kinase activity. A critical early event following ligand binding is activation of the tyrosine kinase catalytic domain (1-3). The receptor itself is one ofthe major intracellular targets for the tyrosine kinase activity and becomes autophosphorylated. One function of receptor autophosphorylation is to up-regulate the activity of the tyrosine kinase catalytic domain (4, 5). However, for most tyrosine kinase receptors, autophosphorylation functions to create high-affinity binding sites for signaling molecules that contain src homology (SH) 2 domains (1-3). SH2 domains are modular, noncatalytic domains of about 100 amino acids that are found in various distinct signaling molecules and function by binding a phosphotyrosine moiety in the context of short amino acid sequences (1, 6, 7) . Since target molecules must bind to activated receptors to activate signaling pathways, autophosphorylation of specific tyrosine residues on a given receptor determines which signaling pathways are recruited by the receptor.
Although ligand binding to the insulin receptor activates the receptor tyrosine kinase and leads to receptor autophosphorylation, the insulin receptor interacts poorly, if at all, with known SH2 domain-containing target proteins (6, 8) .
Instead, the insulin receptor utilizes an alternative strategy to activate signaling molecules that contain SH2 domains. Insulin or IGF-1 stimulation results in tyrosine phosphorylation of a 185-kDa intermediate protein, insulin receptor substrate 1 (IRS-1), which functions as a docking protein for SH2 domain-containing signaling molecules. Tyrosine-phosphorylated IRS-1 binds the SH2 domains of p85-associated phosphatidylinositol 3'-kinase (PI-3 kinase), resulting in PI-3
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kinase activation (9) (10) (11) . Recently, it was shown that GRB2 couples the Ras guanine nucleotide releasing factor (GRF), Sos, to IRS-1 (12) (13) (14) . The finding that GRB2 overexpression enhances insulin-induced activation of Ras and Map kinases suggests that binding of GRB2 to IRS-1 may directly link the insulin receptor to Ras signaling pathways (13) .
We wanted to test whether IRS-1 interacts with other SH2 domain-containing signaling proteins and thereby provides additional links between the insulin receptor and other signaling pathways. One candidate protein is Nck, a ubiquitously expressed protein composed of one SH2 and three SH3 domains (15) . Several recent findings have implicated Nck as a potentially important signaling molecule. First, Nck is an oncoprotein; cellular overexpression of Nck transforms NIH 3T3 and 3Y1 rat fibroblasts (16, 17) . In addition, Nck is phosphorylated in response to activation of various cytoplasmic and receptor tyrosine kinases and Nck has been shown to bind, via its SH2 domain, the activated platelet-derived growth factor and epidermal growth factor receptors (16) (17) (18) (19) . It is thought that Nck might regulate signaling pathways by functioning as an adaptor protein, coupling the activated receptor to an as yet-to-be defined catalytic molecule whose activity is modulated by binding of Nck to the activated receptor.
In this report, we show that insulin stimulation results in the formation of a stable complex between tyrosinephosphorylated IRS-1 and the SH2 domain of Nck. Although Nck binds IRS-1 in insulin-stimulated cells, Nck is not a substrate either for the insulin receptor or for the kinases activated downstream from the insulin receptor. Moreover, we show that IRS-1 binds Nck through a different phosphotyrosine-containing motif than that required for binding p85 and GRB2 and that after insulin stimulation a single IRS-1 molecule can simultaneously bind Nck, GRB2, and p85 in vivo. These findings support the idea that IRS-1 forms the core for a large signaling complex through which the insulin receptor regulates various distinct signaling pathways.
MATERIALS AND METHODS
Cell Lines and Antibodies. CHO/IR cells are Chinese hamster ovary cells that overexpress the insulin receptor (10) . Cells were grown in F12 medium supplemented with 10% fetal bovine serum. Rabbit polyclonal anti-Nck antibody was raised against a full-length Nck-glutathione S-transferase (GST) fusion protein (16) . IRS-1 antibodies (PEP 80), anti-GRB2 antibodies (86 and 50), and anti-p85 and antiphosphotyrosine antibodies have been described (12) . Immunoprecipitation 100 nM bovine insulin. Cell lysis, immunoprecipitation, and immunoblotting were performed as described (20) .
IRS-1 Produced in Insect Cells. Baculovirus-expressed IRS-1 was collected from SF9 cells and purified as described (10, 11) . Purified IRS-lbac was then phosphorylated with [y32P]ATP using wheat germ agglutinine purified insulin receptor (10, 11) .
Peptide Synthesis and Purification. Peptides were prepared by conventional methods using a Milligen/Biosearch 9600 synthesizer (21) . Phosphopeptides were prepared using FmocTyr[OP(OCH2)2]. All peptides were purified by HPLC and subjected to amino acid analysis.
GST Fusion Proteins and in Vitro Binding Assays. Oligonucleotides flanking the regions of interest and containing appropriate restriction sites were synthesized and PCR was used to amplify the appropriate DNA fragments (12) . The amplified products were cloned into pGEX3X and the fusion proteins were purified by affinity chromatography using immobilized glutathione agarose beads. The following fusion proteins were produced: full-length Nck, the SH2 domain of Nck, the three SH3 domains of Nck, the N and C SH2 domains of p85, and full-length GRB2.
To assess the binding of IRS-1 to GST fusion proteins in vitro, 0.5 Ag of GST fusion protein was immobilized on glutathione agarose beads and incubated with 32P-labeled IRS-lbac in buffer containing 50 mM Tris HCl (pH 7.8), 250 mM NaCl, 10 mM dithiothreitol, and 0.5% Triton X-100 (14) . After a 30-min incubation at 4°C, the beads were washed with HNTG (20 mM Hepes, pH 7.5/10% glycerol/0.1% Triton X-100/150 mM NaCl), and after boiling in sample buffer, the proteins were separated on an 8% SDS/polyacrylamide gel. Bound IRS-1 was visualized by autoradiography.
Peptide inhibition studies were done in an identical manner with the exception that 100 nM of fusion protein was preincubated with peptides for 30 min at 4°C prior to the addition oflabeled IRS-1. The amount ofbound IRS-1 was quantitated using a PhosphorImager, with 100o binding defined as the amount of IRS-1 bound in the absence of competing peptide.
PI-3 Kinase Assay. PI-3 kinase was assayed from immunoprecipitated proteins as described (22 the various domains of Nck were produced. In vitro binding of IRS-1 to these fusion proteins was determined (see Materials and Methods), and bound IRS-1 was detected by SDS/PAGE and autoradiography. Tyrosine-phosphorylated IRS-1 bound a full-length Nck GST-fusion protein (Fig. 2 , GST-Nck). The SH2 domain of Nck was responsible for binding IRS-1; a fusion protein composed of only the SH2 domain ofNck bound tyrosine-phosphorylated IRS-1 with an affinity similar to that of the full-length fusion protein (Fig. 2 , GST-Nck SH2). We did not detect binding of IRS-1 to fusion proteins containing the three SH3 domains ofNck (GST-Nck SH3) or to GST alone (GST), indicating that the interaction between the SH2 domain of Nck and IRS-1 is specific.
Nck Phosphorylation Is Not Increased After Insulin Stimulation. Nck has been shown to undergo tyrosine as well as threonine and serine phosphorylation in response to activation of various cell surface receptors (16) (17) (18) (19) . This suggests that, in response to growth factor stimulation, Nck may be regulated by phosphorylation. To Various GST fusion proteins were incubated with 32P-labeled IRS-lbac for 1 hr at 4°C. After washing, proteins were separated by SDS/PAGE (8%) and bound IRS-1 was visualized by autoradiography. The GST fusion proteins used are GST alone (GST), full-length Nck (GST-Nck), the SH2 domain of Nck (GST-Nck SH2), the three SH3 domains of Nck (GST-Nck SH3), and full-length GRB2 (GST-GRB2).
stimulation results in phosphorylation of Nck, Nck was immunoprecipitated from orthophosphate-labeled cell lysates. Phosphorylation of Nck was determined by SDS/ PAGE followed by autoradiography. We were unable to detect a change in Nck phosphorylation after insulin stimulation (Fig. 3, lanes 3 and 4) . Phosphoamino acid analysis of Nck from control and insulin-stimulated cells demonstrated that Nck was phosphorylated predominantly on serine residues, although a very small amount of tyrosine phosphorylation was also detected (Fig. 3, panels 2 and 3) . There was, however, no detectable change in Nck phosphorylation after insulin stimulation. The failure to detect an increase in Nck phosphorylation was not secondary to poor stimulation ofthe cells with insulin; phosphorylated IRS-1 coimmunoprecipitated with Nck in the stimulated cell lysates. Corroborating these findings, we were unable to detect tyrosine-phosphorylated Nck before or after insulin stimulation, using antibodies to phosphotyrosine (Fig. 1, lanes 6 and 7) . These results suggest that the regulation of Nck by insulin is not mediated by phosphorylation of Nck.
IRS-1 Simultaneously Binds Several SH2 Domain-Containing Proteins. We have recently demonstrated that a single IRS-1 molecule can bind the SH2 domains of p85 and GRB2 and that the SH2 domains of each molecule recognize distinct phosphotyrosines on IRS-1 (12). To investigate whether IRS-1 can simultaneously bind Nck, GRB2, and p85, we assessed whether GRB2, p85, and PI-3 kinase activity coimmunoprecipitates, using antibodies to Nck. Insulin stimula- v** 88-@ tion resulted in a marked increase in the amount of GRB2, p85, and P13 kinase activity that coimmunoprecipitated with antibodies to Nck (Fig. 4) . The interaction between Nck, p85, and GRB2 appears to be mediated by the binding of the SH2 domains of each molecule to tyrosine-phosphorylated IRS-1. Nck Binds a Phosphotyrosine Residue on IRS-1 That Is Distinct from Those Bound by p85 and GRB2. The finding that IRS-1 can simultaneously interact with GRB2, p85, and Nck suggests that the SH2 domain of Nck recognizes a phosphotyrosine residue on IRS-1 different from those recognized by the SH2 domains of p85 and GRB2. We have previously shown that the SH2 domain of GRB2 binds tyrosine 895 of IRS-1 through a YVNI motifand that the SH2 domains ofp85 bind IRS-1 through several YMXM and YXXM motifs (10, 12) . To determine the binding site of Nck to IRS-1, phosphopeptides corresponding to known tyrosine phosphorylation sites on IRS-1 were synthesized and the ability of these phosphopeptides to inhibit the binding of IRS-1 to Nck was assessed. In designing peptides for competition studies, we used the information, obtained using degenerate phosphopeptide libraries, that the SH2 domain of Nck binds a synthetic phosphopeptide containing the sequence pYDEP (23) . The SH2 domain of Nck most frequently selected an aspartic acid residue at a position +1 from the phosphotyrosine. Since rat IRS-1 contains only a single tyrosine residue (Y147), followed by an aspartic acid, we determined whether a phosphopeptide corresponding to the sequence around Y147 inhibited the binding of IRS-1 to Nck. that a phosphopeptide corresponding to the sequence around tyrosine 147 of rat IRS-1 consistently inhibited the binding of IRS-1 to Nck by >60%o. This inhibition was specific; binding of IRS-1 to Nck was not inhibited by either a phosphopeptide corresponding to the binding site of GRB2 to IRS-1 (pY895) or a phosphopeptide (pY727) that has been shown to inhibit the binding of p85 to IRS-1 (Fig. 5 A and C) . In addition, various other phosphopeptides corresponding to known tyrosine phosphorylation sites in IRS-1 did not inhibit Nck binding to IRS-1 (Fig. 5C) .
The pY147 peptide specifically inhibits the binding of Nck to IRS-1. Under conditions in which the binding of IRS-1 to Nck was inhibited, the pY147 peptide did not competitively inhibit the binding of IRS-1 to fusion proteins containing either the p85 or the GRB2 SH2 domains (Fig. 5B) . However, phosphopeptides corresponding to binding sites on IRS-1 for GRB2 (pY895) and p85 (pY727) inhibited the binding of IRS-1 to GRB2 and p85, respectively. regulate signal transduction pathways (1-3, 6, 10, 13, 24-28 ). GRB2 and p85 are tightly associated with catalytic molecules and act as adaptors linking these molecules to phosphotyrosine-containing proteins. The interaction of the adaptor proteins either with the autophosphorylated receptor or with intermediate phosphotyrosine-containing proteins, such as IRS-1 or Shc, is thought to regulate the activity of the associated catalytic domain (1-3). Based on these findings, a great effort has been undertaken to identify proteins with SH2 domains that respond to growth factor stimulation by forming stable complexes with phosphotyrosine-containing molecules. One protein of interest, Nck, is similar to GRB2 in that it is composed virtually entirely of SH2 and SH3 domains.
In this report we demonstrate that Nck, via its SH2 domain, forms a stable complex with tyrosine-phosphorylated IRS-1 in insulin-stimulated cells.
The importance of IRS-1 in regulating signaling pathways that are stimulated by the insulin and IGF-1 receptors has been established by indirect and direct evidence. Mutations in the juxtamembrane region of the insulin receptor that eliminate tyrosine 960 result in a receptor unable to tyrosine phosphorylkte-IRS-i (29) . Although the tyrosine kinase is active, these mutated receptors are unable to stimulate DNA or glycogen synthesis (29, 30) . More recently, IRS-1 has been shown to directly regulate PI-3 kinase; binding of p85 to IRS-1 leads to activation of the 110-kDa PI-3 kinase catalytic domain (10) . We have recently shown that tyrosinephosphorylated IRS-1 also binds GRB2 and that this interaction couples the Ras GRF Sos, bound to GRB2's SH3 domains, to IRS-1 (12, 13) . The finding that GRB2 overexpression potentiates the activation of Ras signaling pathways by insulin suggests that binding of GRB2 to IRS-1 may function to activate Sos (13) .
It is envisioned that the binding of Nck to IRS-1 may regulate an as-yet-to-be defined signaling pathway. The finding that cellular overexpression of Nck is transforming implies that Nck can activate mitogenic signaling pathways (16, 17) . However, in contrast to p85 and GRB2, for which the catalytic component is known, the catalytic component that associates with Nck is unknown and thus Nck's role in growth factor signaling remains unclear. Recently it has been shown that SH3 domains regulate protein-protein interactions by binding short proline-rich motifs present in effector molecules (31) (32) (33) (34) . The signaling pathways regulated by adaptor proteins are most likely to be defined by the identity of the specific catalytic molecule(s) coupled to each SH3 domain. For example, the SH3 domains of GRB2 bind a proline-rich sequence present in the Ras exchange factor Sos (33, 34) , and, as predicted, GRB2 activates Ras in vivo (13, 25, 28) . The SH3 domains of Nck are likely to bind a putative effector protein that is coupled to IRS-1 and other tyrosinephosphorylated proteins through Nck's SH2 domain.
Though it is of particular interest to identify the effector molecules that interact with Nck, it will also be important to determine how the activities of these molecules are regulated by the interaction of Nck with IRS-1. Previous studies have shown that Nck is a target for various tyrosine and serine/ threonine kinases (16) (17) (18) (19) . However, we did not detect a change in Nck phosphorylation in response to insulin stimulation. Interestingly, p85 and GRB2 also fail to undergo tyrosine phosphorylation after insulin stimulation (10, 12) . Thus, the insulin receptor does not regulate the function of these adaptor molecules by phosphorylation; rather, it is likely that the interaction between Nck and IRS-1 is analo- with IRS-1 in insulin-stimulated cells may function to reposition Sos adjacent to Ras, in the plasma membrane (13, 35) .
Since the creation of specific SH2 binding sites by a receptor tyrosine kinase determines which signaling pathways are activated by a given receptor (1-3, 6, 7), the identification of SH2 binding motifs is critical to our understanding of signaling specificity. We have found that the SH2 domain of Nck recognizes a binding motif on IRS-1 that is clearly distinguishable from the motif recognized by p85 and GRB2 (12) . This is consistent with our observation that a single IRS-1 molecule can simultaneously interact with p85, GRB2, and Nck. Our competition experiments indicate that Y147 of rat IRS-1 represents at least one potential highaffinity binding site for Nck to IRS-1. Tyrosine 147 of rat IRS-1 is followed by an aspartic acid in the +1 position; this aspartic acid was the most frequently selected residue in experiments using a phosphopeptide library to identify sequence-specific high-affinity binding motifs for the SH2 domain of Nck, suggesting that an aspartic acid at the +1 position is important for high-affinity binding of the SH2 domain of Nck to phosphotyrosine. However, it is unlikely that this motif is the only one to interact with the SH2 domain of Nck. This motif is not conserved in human IRS-1, yet Nck binds tyrosine-phosphorylated human IRS-1 with high affinity in vitro (M.G.M. and M.F.W., unpublished observation). Furthermore, Nck has been shown to bind a very different sequence in the platelet-derived growth factor receptor (36); this sequence is not found in rat or human IRS-1.
The ability of a single SH2 domain to bind distinct motifs has been reported previously (37) . The SH2 domain of Src binds to the tyrosine-phosphorylated juxtamembrane region of the platelet-derived growth factor receptor and also to a sequence in the C terminus of Src; these two sequences are only weakly similar (37) . Screening of degenerate phosphopeptide libraries identified yet another sequence, pYEEI, that bound Src's SH2 domain (23) , and crystallographic analysis revealed that all three amino acids after the phosphotyrosine make specific contacts with the SH2 domain of Src (38) . Although the SH2 domain of Src may bind different motifs with different affinities (23) , further clarification of the structural basis for the interaction of an SH2 domain with many different motifs will require determining the structure, by x-ray crystallography or NMR, of the SH2 domain complexed with the different tyrosine-phosphorylated peptides.
Our finding that IRS-1 binds Nck reinforces the concept that, in contrast with most receptor tyrosine kinases, which interact directly with SH2 domain-containing signaling molecules, the insulin and IGF-1 receptors employ IRS-1 as an intermediate SH2 domain-docking protein. Recent studies have shown that Nck is a target for various cell surface receptors. Our demonstration that Nck is also recruited to the insulin signaling pathway supports the idea that Nck is an essential component of a common pathway used by many receptors. Identifying the activity that Nck couples to IRS-1 is likely to lead to the elucidation of the exact functions regulated by Nck in insulin-stimulated cells.
